Abstract
Neurofibrillary degeneration has primary and pivotal involvement in the pathogenesis of Alzheimer disease (AD) and other tauopathies. The inhibition of this lesion offers a promising therapeutic approach. The microtubule-associated protein (MAP) tau is abnormally hyperphosphorylated in the brain of patients with AD, and in this form it is the major protein subunit of paired helical filaments/neurofibrillary tangles (PHF/NFT). The abnormal tau that is polymerized into PHF/NFT is apparently inert and has no effect on microtubule assembly in vitro. The cytosolic abnormally hyperphosphorylated tau from AD brain, the AD P-tau, does not promote in vitro microtubule assembly but, instead, sequesters normal tau, MAP1, and MAP2 and inhibits microtubule assembly. The AD P-tau readily self-assembles in vitro into tangles of PHF/straight filaments, and this self-assembly requires the abnormal hyperphosphorylation of this protein. Although, to date, an up-regulation of the activity of a tau kinase has not been established, the activity of phosphoseryl/phosphothreonyl protein phosphatase (PP)-2A, which regulates the phosphorylation of tau, is compromised in AD brain. Thus, modulation of the activities of pp-2A and one or more tau kinases and inhibition of the sequestration of normal MAPs by ADP-tau offer promising therapeutic opportunities to inhibit neurofibrillary degeneration and the diseases characterized by this lesion. Development of high-throughput screening assays for potential drugs aimed at these therapeutic targets is currently under way.
Similar content being viewed by others
References
Alafuzoff I., Iqbal K., Friden H., Adolfson R., and Winblad B. (1987) Histopathological criteria for progressive dementia disorders: clinical-pathological correlation and classification by multivariate data analysis. Acta Neuropathol. (Berlin) 74, 209–225.
Alonso A. del C., Grundke-Iqbal I., and Iqbal K. (1996) Alzheimer’s disease hyperphosphorylated tau sequesters normal tau into tangles of filaments and dis-assembles microtubules. Nat. Med. 2, 783–787.
Alonso A. del C., Grundke-Iqbal I., Barra H. S., and Iqbal K. (1997) Abnormal phosphorylation of tau and the mechanism of Alzheimer neurofibrillary degeneration: Sequestration of MAP1 and MAP2 and the disassembly of microtubules by the abnormal tau. Proc. Natl. Acad. Sci. U.S.A. 94, 298–303.
Alonso A. del C., Zaidi T., Grundke-Iqbal I., and Iqbal K. (1994) Role of abnormally phosphorylated tau in the breakdown of microtubules in Alzheimer disease. Proc. Natl. Acad. Sci. U.S.A. 91, 5562–5566.
Alonso A. del C., Zaidi T., Novak H. S., Barra H. S., Grundke-Iqbal I., and Iqbal K. (2001b) Interaction of tau isoforms with Alzheimer’s disease abnormally hyperphosphorylated tau and in vitro phosphorylation into the disease-like protein. J. Biol. Chem. 276, 37,967–37,973.
Alonso A. del C., Zaidi T., Novak M., Grundke-Iqbal I., and Iqbal K. (2001a) Hyperphosphorylation induces self-assembly of tau into tangles of paired helical filaments/straight filaments. Proc. Natl. Acad. Sci. U.S.A. 98, 6923–6928.
Arrigada P. A., Growdon J. H., Hedley-White E. T., and Hyman B. T. (1992) Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer’s disease. Neurology 42, 631–639.
Bennecib M., Gong C.-X., Grundke-Iqbal I., and Iqbal K. (2001) Inhibition of PP-2A upregulates CaMKII in rat forebrain and induces hyperphosphorylation of tau at Ser 262/356. FEBS Lett. 490, 15–22.
Cohen P. (1989) The structure and regulation of protein phosphatases. Annu. Rev. Biochem. 58, 453–508.
Cohen P., Alemany S., Hemmings B. A., Resink T. J., Stralfors P., and Lim Tung H. Y. (1988) Protein Phosphatase-1 and Protein Phosphatase-2A from rabbit skeletal muscle. Methods Enzymol. 159, 390–408,.
Dickson D. W., Crystal H. A., Mattiace L. A., Masur D. M., Blau A. D., Davies P., et al. (1991) Identification of normal and pathological aging in prospectively studied non-demented elderly humans. Neurobiol. Aging 13, 179–189.
Dickson D. W., Farlo J., Davies P., Crystal H., Fuld P., and Yen S. H. (1988) Alzheimer’s disease, A double-labeling immunohistochemical study of senile plaques. Am. J. Pathol. 132, 86–101.
Gong C.-X., Lidsky T., Wegiel J., Zuck L., Grundke-Iqbal I., and Iqbal K. (2000) Phosphorylation of microtubule-associated protein tau is regulated by protein phosphatase 2A in mammalian brain. J. Biol. Chem. 275, 5535–5544.
Gong C.-X., Shaikh S., Wang J.-Z., Zaidi T., Grundke-Iqbal I., and Iqbal K. (1995) Phosphatase activity towards abnormally phosphorylated τ: decrease in Alzheimer disease brain. J. Neurochem. 65, 732–738.
Gong C.-X., Singh T. J., Grundke-Iqbal I., and Iqbal K. (1993) Phosphoprotein phosphatase activities in Alzheimer disease brain. J. Neurochem. 61, 921–927.
Grundke-Iqbal I., Iqbal K., Quinlan M., Tung Y.-C., Zaidi M. S., and Wisniewski H. M. (1986a) Microtubule-associated protein tau: A component of Alzheimer paired helical filaments. J. Biol. Chem. 261, 6084–6089.
Grundke-Iqbal I., Iqbal K., Tung Y.-C., Quinlan M., Wisniewski H. M., and Binder L. I. (1986b) Abnormal phosphorylation of the microtubule associated protein tau in Alzheimer cytoskeletal pathology. Proc. Natl. Acad. Sci. U.S.A. 83, 4913–4917.
Hu Y. Y., He S. S., Wang X., Duan Q. H., Grundke-Iqbal I., Iqbal K., and Wang J. Z. (2002) Levels of nonphosphorylated and phosphorylated tau in CSF of Alzheimer disease patients: An ultrasensitive bienzyme-substrate-recycle enzyme-linked immunosorbent assay. Am. J. Pathol. 160, 1269–1278.
Hutton M. et al., (1998) Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17. Nature 393, 702–705.
Iqbal K., Alonso A. del C., El-Akkad E., Gong C.-X., Haque N., Khatoon S., et al. (2002) Significance and mechanism of Alzheimer neurofibrillary degeneration and therapeutic targets to inhibit this lesion. J. Mol. Neurosci. 19, 95–99.
Iqbal K., Alonso A. del C., Gondal J. A., Gong C.-X., Haque N., Khatoon S., et al. (2000) Mechanism of neurofibrillary degeneration and pharmacologic therapeutic approach. J. Neural Transm. 59, 213–222.
Iqbal K. and Grundke-Iqbal I. (2000) Metabolic hypothesis, mechanism and therapeutic targets of Alzheimer neurofibrillary degeneration. Neurosci. News 3, 14–20.
Iqbal K., Grundke-Iqbal I., Smith A. J., George L., Tung Y.C., and Zaidi T. (1989) Identification and localization of a tau peptide to paired helical filaments of Alzheimer disease. Proc. Natl. Acad. Sci. U.S.A. 86, 5646–5650.
Iqbal K., Grundke-Iqbal I., Zaidi T., Merz P.A., Wen G.Y., Shaikh S. S., Wisniewski H. M., et al. (1986) Defective brain microtubule assembly in Alzheimer’s disease. Lancet 2, 421–426.
Iqbal K., Zaidi T., Bancher C., and Grundke-Iqbal I. (1994) Alzheimer paired helical filaments: Restoration of the biological activity by dephosphorylation. FEBS Lett. 349, 104–108.
Katzman R., Terry R. D., DeTeresa R., Brown R., Davies P., Fuld P., et al. (1988) Clinical, pathological and neurochemical changes in dementia: a subgroup with preserved mental status and numerous neocortical plaques. Ann. Neurol. 23, 138–144.
Khatoon S., Grundke-Iqbal I., and Iqbal K. (1992) Brain levels of microtubule-associated protein tau are elevated in Alzheimer’s disease: A radioimmuno-slot-blot assay for nanograms of the protein. J. Neurochem. 59, 750–753.
Khatoon S., Grundke-Iqbal I., and Iqbal K. (1994) Levels of normal and abnormally phosphorylated tau in different cellular and regional compartments of Alzheimer disease and control brains. FEBS Lett. 351, 80–84.
Köpke E., Tung Y.-C., Shaikh S., Alonso A. del C., Iqbal K., and Grundke-Iqbal I. (1993) Microtubule associated protein tau: abnormal phosphorylation of non-paired helical filament pool in Alzheimer disease. J. Biol. Chem. 268, 24,374–24,384.
Lee V. M.-Y., Balin B. J., Otvos L., Jr., and Trojanowski J. Q. (1991) A68: A major subunit of paired helical filaments and derivatized forms of normal tau. Science 251, 675–678.
Li M., Guo H., and Damuni Z. (1995) Purification and characterization of two potent heat-stable protein inhibitors of protein phosphatase 2A from bovine kidney. Biochemistry 34, 1988–1996.
Li M., Makkinje A., and Damuni Z. (1996a) Molecular identification of I1 PP2A, a novel potent heat-stable inhibitor protein of protein phosphatase 2A. Biochemistry 35, 6998–7002.
Li M., Makkinje A., and Damuni Z. (1996b) The myeloid leukemia-associated protein SET is a potent inhibitor of Protein Phosphatase 2A. J. Biol. Chem. 271, 11,059–11,062.
Mah V. H., Eskin T. A., Kazee A. M., Lapham L., and Higgins G. A. (1992) In situ hybridization of calcium/calmodulin dependent protein kinase II and tau mRNAs; species differences and relative preservation in Alzheimer’s disease. Brain Res. Mol. Brain Res. 12, 85–94.
Morsch R., Simon W., and Coleman P. D. (1999) Neurons may live for decades with neurofibrillary tangles. J. Neuropathol. Exp. Neurol. 58, 188–197.
Oliver C. J. and Shenolikar S. (1998) Physiologic importance of protein phosphatase inhibitors. Front. Biosci. 3, 961–972.
Poorkaj P., Bird T. D., Wijsman E., Nemens E., Garruto R. M., Anderson L., et al. (1998) Tau is a candidate gene for chromosome 17 frontotemporal dementia. Ann. Neurol. 43, 815–825.
Sisodia S. S. and St. George-Hyslop P. H. (2002) γ-Secretase, Notch, Aβ and Alzheimer’s Disease: Where do the presenilins fit in? Nat. Neurosci. 3, 281–290.
Spillantini M. G., Murrell J. R., Goedert M., Farlow M. R., Klug A., and Ghetti B. (1998) Mutation in the tau gene in familial multiple system tauopathy with presenile dementia. Proc. Natl. Acad. Sci. U.S.A. 95, 7737–7741.
Ulitzur N., Rancano C., and Pfeffer S. R. (1997) Biochemical characterization of mapmodulin, a protein that binds microtubule-associated proteins. J. Biol. Chem. 272, 30,577–30,582.
von Lindern M., van Baal S., Wiegant J., Raap A., Hagemeijer A., and Grosveld G. (1992) can, a putative oncogene associated with myeloid leukemogenesis, may be activated by fusion of its 3′ half to different genes: Characterization of the set gene. Mol. Cell. Biol. 12, 3346–3355.
Walaas S. I. and Greengard P. (1991) Protein phosphorylation and neuronal function. Pharmacol. Rev. 43, 299–349.
Wang J.-Z., Gong C.-X., Zaidi T., Grundke-Iqbal I., and Iqbal K. (1995) Dephosphorylation of Alzheimer paired helical filaments by protein phosphatase-2A and -2B. J. Biol. Chem. 270, 4854–4860.
Wang J.-Z., Grundke-Iqbal I., and Iqbal K. (1996) Restoration of biological activity of Alzheimer abnormally phosphorylated by dephosphorylation with protein phosphatase-2A,-2B and -1. Mol. Brain Res. 38, 200–208.
Weingarten M. D., Lockwood A. H., Hwo S. Y., and Kirschner M. W. (1975) A protein factor essential for microtubule assembly. Proc. Natl. Acad. Sci. USA 72, 1858–1862.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Iqbal, K., Alonso, A.d.C., El-Akkad, E. et al. Alzheimer neurofibrillary degeneration. J Mol Neurosci 20, 425–429 (2003). https://doi.org/10.1385/JMN:20:3:425
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1385/JMN:20:3:425